Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




Apr
28
Today In Oncology
RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer
Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants
ACP Issues Controversial New Breast Cancer Screening Guidelines
Educational Disparities in Young-Onset Colorectal Cancer Mortality
Breast Cancer Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxicity
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo